ATE240940T1 - Arylsulfonanilid-harnstoffe - Google Patents

Arylsulfonanilid-harnstoffe

Info

Publication number
ATE240940T1
ATE240940T1 AT99969408T AT99969408T ATE240940T1 AT E240940 T1 ATE240940 T1 AT E240940T1 AT 99969408 T AT99969408 T AT 99969408T AT 99969408 T AT99969408 T AT 99969408T AT E240940 T1 ATE240940 T1 AT E240940T1
Authority
AT
Austria
Prior art keywords
agents
compositions
arylsulfonanilide
ureas
hypercholesterolemia
Prior art date
Application number
AT99969408T
Other languages
English (en)
Inventor
Jonathan B Houze
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Application granted granted Critical
Publication of ATE240940T1 publication Critical patent/ATE240940T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AT99969408T 1998-09-23 1999-09-21 Arylsulfonanilid-harnstoffe ATE240940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10088898P 1998-09-23 1998-09-23
PCT/US1999/022013 WO2000017159A1 (en) 1998-09-23 1999-09-21 Arylsulfonanilide ureas

Publications (1)

Publication Number Publication Date
ATE240940T1 true ATE240940T1 (de) 2003-06-15

Family

ID=22282047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99969408T ATE240940T1 (de) 1998-09-23 1999-09-21 Arylsulfonanilid-harnstoffe

Country Status (23)

Country Link
US (3) US6214880B1 (de)
EP (1) EP1115701B1 (de)
JP (1) JP3926983B2 (de)
KR (1) KR100642184B1 (de)
CN (1) CN100335461C (de)
AT (1) ATE240940T1 (de)
AU (1) AU747663B2 (de)
BR (1) BR9913903A (de)
CA (1) CA2343204C (de)
CZ (1) CZ2001934A3 (de)
DE (1) DE69908156T2 (de)
DK (1) DK1115701T3 (de)
EA (1) EA003924B1 (de)
ES (1) ES2194547T3 (de)
HU (1) HUP0103884A3 (de)
IL (2) IL142066A0 (de)
NO (1) NO20011453L (de)
NZ (1) NZ510435A (de)
PL (1) PL198394B1 (de)
PT (1) PT1115701E (de)
SK (1) SK284757B6 (de)
WO (1) WO2000017159A1 (de)
ZA (1) ZA200102033B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508644D0 (en) * 1995-04-28 1995-06-14 Exxon Chemical Patents Inc Fuel compositions
BR9913903A (pt) * 1998-09-23 2001-07-03 Tularik Inc Composto, método para tratar ou impedir um estado doentio, e, composição farmacêutica
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
EP1206256B8 (de) * 1999-07-29 2005-06-29 Amgen, Inc. Kombination therapie mit pentafluorobenzenesulfonamid und platin-derivate
CO5280089A1 (es) * 2000-03-16 2003-05-30 Smithkline Beecham Corp Antagonistas del receptor il-8
US6664259B2 (en) 2000-03-16 2003-12-16 Smithkline Beecham Corporation Il-8 receptor antagonists
UY26627A1 (es) * 2000-03-24 2001-09-28 Smithkline Beecham Corp Antagonistas de receptores de il-8
AU2001288623A1 (en) 2000-09-05 2002-03-22 Tularik, Inc. Fxr modulators
US6822001B2 (en) 2000-11-03 2004-11-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2002306604B2 (en) 2001-02-28 2007-09-13 Onconova Therapeutics, Inc. N-(Aryl)-2-arylethenesulfonamides and therapeutic uses thereof
AUPR738301A0 (en) * 2001-08-30 2001-09-20 Starpharma Limited Chemotherapeutic agents
CA2474702A1 (en) * 2002-01-30 2003-08-07 Tularik Inc Heterocyclic arylsulfonamidobenzylic compounds
DE60324104D1 (en) * 2002-01-30 2008-11-27 Amgen Inc Arylsulfonamidobenzylverbindungen
JP4538233B2 (ja) 2002-02-28 2010-09-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性障害治療用の、アミノ置換されたスルホンアニリド及びその誘導体
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
AU2004264354A1 (en) * 2003-08-12 2005-02-24 Amgen Inc. Arylsulfonamidobenzylic compounds
US20050124664A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Urea thiadiazole inhibitors of plasminogen activator inhibior-1
US20050154455A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
US20060062822A1 (en) * 2004-09-21 2006-03-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20070027530A1 (en) * 2005-07-26 2007-02-01 Medtronic Vascular, Inc. Intraluminal device, catheter assembly, and method of use thereof
FI20055498A0 (fi) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamidijohdannaisia
US20070067020A1 (en) * 2005-09-22 2007-03-22 Medtronic Vasular, Inc. Intraluminal stent, delivery system, and a method of treating a vascular condition
MY145810A (en) * 2006-04-21 2012-04-30 Smithkline Beecham Corp Il-8 receptor antagonists
CN101495113A (zh) * 2006-04-21 2009-07-29 史密丝克莱恩比彻姆公司 Il-8受体拮抗剂
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
AR061571A1 (es) * 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un
KR20100096101A (ko) * 2007-10-19 2010-09-01 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 박테리아 독성을 억제하는 방법 및 이에 대한 화합물
EP2385831A4 (de) * 2009-01-09 2014-03-26 Uab Research Foundation Kleinmolekulare hemmer von nads, namnat und nmnat
ES2728260T3 (es) * 2012-11-21 2019-10-23 Nippon Soda Co Material de impresión producido utilizando un compuesto no fenólico
US9444712B2 (en) 2012-11-21 2016-09-13 Cisco Technology, Inc. Bandwidth on-demand services in multiple layer networks
JPWO2017170826A1 (ja) * 2016-03-30 2019-02-14 味の素株式会社 グルカゴン様ペプチド−１受容体作用増強活性を有する化合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
DE622494C (de) 1932-01-03 1935-11-29 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Mono- bzw. Polynitropolysulfonen und deren Reduktionsprodukten
US2358365A (en) 1940-08-03 1944-09-19 Parke Davis & Co Sulphonamide derivatives and process for obtaining the same
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH362688A (de) 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB938890A (en) 1961-02-03 1963-10-09 Boots Pure Drug Co Ltd New fungicidal compositions and compounds
CH504416A (de) 1966-12-05 1971-03-15 Ciba Geigy Ag Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
FR2456731A1 (fr) 1979-05-16 1980-12-12 Choay Sa Nouveaux derives substitues d'ary
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
DE3905075A1 (de) 1989-02-18 1990-08-30 Hoechst Ag Benzolsulfonamide und verfahren zu ihrer herstellung
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
ATE167473T1 (de) 1990-08-20 1998-07-15 Eisai Co Ltd Sulfonamid-derivate
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
JP3421349B2 (ja) 1996-02-22 2003-06-30 テュラリク インコーポレイテッド ペンタフルオロベンゼンスルホンアミドおよび類縁体
CA2260777C (en) * 1996-07-19 2006-06-13 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
WO1999024407A1 (en) 1997-11-10 1999-05-20 Array Biopharma, Inc. Compounds which inhibit tryptase activity
CA2300197A1 (en) 1997-12-23 1999-07-01 Warner-Lambert Company Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
BR9913903A (pt) * 1998-09-23 2001-07-03 Tularik Inc Composto, método para tratar ou impedir um estado doentio, e, composição farmacêutica
EP1206256B8 (de) * 1999-07-29 2005-06-29 Amgen, Inc. Kombination therapie mit pentafluorobenzenesulfonamid und platin-derivate

Also Published As

Publication number Publication date
ES2194547T3 (es) 2003-11-16
US20010027211A1 (en) 2001-10-04
KR100642184B1 (ko) 2006-11-10
BR9913903A (pt) 2001-07-03
SK4002001A3 (en) 2001-09-11
PL346797A1 (en) 2002-02-25
DE69908156D1 (de) 2003-06-26
JP2002526472A (ja) 2002-08-20
IL142066A (en) 2006-07-05
AU747663B2 (en) 2002-05-16
NO20011453L (no) 2001-05-23
HK1038913A1 (en) 2002-04-04
US7060718B2 (en) 2006-06-13
CN1319088A (zh) 2001-10-24
EP1115701B1 (de) 2003-05-21
IL142066A0 (en) 2002-03-10
CZ2001934A3 (cs) 2001-08-15
WO2000017159A1 (en) 2000-03-30
ZA200102033B (en) 2001-09-12
AU6058099A (en) 2000-04-10
US20030207864A1 (en) 2003-11-06
SK284757B6 (sk) 2005-11-03
HUP0103884A3 (en) 2002-11-28
US6214880B1 (en) 2001-04-10
DE69908156T2 (de) 2003-12-24
CN100335461C (zh) 2007-09-05
US6583165B2 (en) 2003-06-24
CA2343204C (en) 2008-04-29
NZ510435A (en) 2003-04-29
DK1115701T3 (da) 2003-06-23
CA2343204A1 (en) 2000-03-30
EA003924B1 (ru) 2003-10-30
KR20010079892A (ko) 2001-08-22
PL198394B1 (pl) 2008-06-30
EA200100376A1 (ru) 2001-08-27
NO20011453D0 (no) 2001-03-22
PT1115701E (pt) 2003-09-30
HUP0103884A2 (hu) 2002-05-29
JP3926983B2 (ja) 2007-06-06
EP1115701A1 (de) 2001-07-18

Similar Documents

Publication Publication Date Title
ATE240940T1 (de) Arylsulfonanilid-harnstoffe
PT1005453E (pt) Compostos de benzeno substituido como agentes de reducao antiproliferativa
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
YU49101A (sh) Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze
DE60023853D1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
TR200000059T2 (tr) Piridin türevleri
ATE248845T1 (de) Arylsulfonanilid-phosphate
SE0003476D0 (sv) Compounds
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
PT1244643E (pt) Inibidores da triptase
DE602004007284D1 (de) Pyrimidine als inhibitoren von phosphoinositid-3-kinasen (pi3k)
TR200100363T2 (tr) Vitronektin reseptör antagonistleri.
PT1232173E (pt) Derivados do acido fusidico
EP1285911A3 (de) Arylsulfonylanilid-Harnstoffe
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same
DE60305520D1 (de) 2" oxo-voruscharin und derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1115701

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee